Table 3.
Ratios of Rates of Rhabdomyolysis Among All Adverse Events Reported on Statins Relative to the Rate of 4.36% (= 38 of 872) for Rosuvastatin From July 2003 to June 2004
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.